Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8101 USD | -3.56% | -1.81% | +42.12% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.12% | 32.99M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- HC Wainwright Lowers Price Target on Viracta Therapeutics to $10 From $33, Maintains Buy Rating